We performed a neuro-immune signature-weighted GDA using the genes negatively correlated to GJA1 expression levels (GSNC-GJA1) in the spinal cord of ALS patients (Figure 2 and supplementary Table S1). The gene discussed is GJA1; the disease is amyotrophic lateral sclerosis.